| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Rong-Fu Wang | |
| P2860 | cites work | Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptors | Q80444910 |
| Regulatory T cell suppression and anergy are differentially regulated by proinflammatory cytokines produced by TLR-activated dendritic cells | Q81111394 | ||
| Inducing and expanding regulatory T cell populations by foreign antigen | Q81392563 | ||
| Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848 | Q24298297 | ||
| Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8 | Q24310398 | ||
| Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function | Q24317859 | ||
| Cancer immunotherapy: moving beyond current vaccines | Q24548229 | ||
| Recognition of single-stranded RNA viruses by Toll-like receptor 7 | Q24568101 | ||
| Toll-like receptor signalling | Q24570126 | ||
| Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25– T cells | Q24645614 | ||
| Inflammation and cancer | Q24649640 | ||
| Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3 | Q24672849 | ||
| Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes | Q24676216 | ||
| Human tumor antigens recognized by T lymphocytes | Q24678508 | ||
| Control of regulatory T cell development by the transcription factor Foxp3 | Q27860489 | ||
| Foxp3 programs the development and function of CD4+CD25+ regulatory T cells | Q27860714 | ||
| Pathogen recognition and innate immunity | Q27861084 | ||
| Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases | Q28131652 | ||
| Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway | Q28216760 | ||
| Toll-like receptors in innate immunity | Q28297257 | ||
| Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors | Q28303818 | ||
| Regulatory T cell lineage specification by the forkhead transcription factor foxp3 | Q28510328 | ||
| IRF-7 is the master regulator of type-I interferon-dependent immune responses | Q28511410 | ||
| Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA | Q28513215 | ||
| Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis | Q29396371 | ||
| Toll-like receptor control of the adaptive immune responses | Q29547305 | ||
| Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival | Q29547865 | ||
| Tumour-educated macrophages promote tumour progression and metastasis | Q29614307 | ||
| NF-kappaB: linking inflammation and immunity to cancer development and progression | Q29614597 | ||
| NF-kappaB functions as a tumour promoter in inflammation-associated cancer | Q29614598 | ||
| IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer | Q29614599 | ||
| The immunobiology of cancer immunosurveillance and immunoediting | Q29616246 | ||
| An essential role for Scurfin in CD4+CD25+ T regulatory cells | Q29618395 | ||
| Tolerogenic dendritic cells | Q29618755 | ||
| Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses | Q29619908 | ||
| Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer | Q29620068 | ||
| Continuous control of autoimmune disease by antigen-dependent polyclonal CD4+CD25+ regulatory T cells in the regional lymph node | Q30438088 | ||
| Human tumor antigens for cancer vaccine development | Q33776127 | ||
| TLR7: A new sensor of viral infection | Q33780838 | ||
| Regulatory T cells in autoimmmunity*. | Q33904108 | ||
| The specific regulation of immune responses by CD8+ T cells restricted by the MHC class Ib molecule, Qa-1. | Q33932690 | ||
| Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter | Q33936032 | ||
| The role of different subsets of T regulatory cells in controlling autoimmunity | Q34096248 | ||
| Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells | Q34147162 | ||
| Immunity against cancer: lessons learned from melanoma. | Q34167925 | ||
| Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer | Q34210036 | ||
| Toll-like receptor 2 controls expansion and function of regulatory T cells | Q34264024 | ||
| Recognition of a new ARTC1 peptide ligand uniquely expressed in tumor cells by antigen-specific CD4+ regulatory T cells | Q34397184 | ||
| Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance | Q34448410 | ||
| Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity | Q34505678 | ||
| Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer. | Q34515741 | ||
| Human CD25+CD4+ T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells. | Q34529123 | ||
| CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity | Q34529549 | ||
| Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide | Q34531452 | ||
| In vivo instruction of suppressor commitment in naive T cells | Q34548023 | ||
| T-cell-mediated suppression of anti-tumor immunity. An explanation for progressive growth of an immunogenic tumor | Q34709824 | ||
| CD4+ CD25+ suppressor T cells: more questions than answers | Q34716304 | ||
| Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis | Q34719541 | ||
| Inability of a fusion protein of IL-2 and diphtheria toxin (Denileukin Diftitox, DAB389IL-2, ONTAK) to eliminate regulatory T lymphocytes in patients with melanoma | Q34943798 | ||
| Enhancing antitumor immune responses: intracellular peptide delivery and identification of MHC class II-restricted tumor antigens | Q35005930 | ||
| Regulatory T cells under scrutiny | Q35092531 | ||
| Regulatory T cells in transplantation tolerance | Q35092535 | ||
| At the crossroads of inflammation and cancer | Q35888450 | ||
| An integrated view of suppressor T cell subsets in immunoregulation | Q35936478 | ||
| Qa-1 restriction of CD8+ suppressor T cells | Q35936489 | ||
| Mechanisms and functional significance of tumour-induced dendritic-cell defects | Q35968465 | ||
| CD4+ CD25+ T cells responding to serologically defined autoantigens suppress antitumor immune responses | Q35978636 | ||
| License to heal: bidirectional interaction of antigen-specific regulatory T cells and tolerogenic APC. | Q36119296 | ||
| Infected site-restricted Foxp3+ natural regulatory T cells are specific for microbial antigens | Q36228356 | ||
| Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells | Q36346300 | ||
| Clonal analysis of cytotoxic and regulatory T cell responses against human melanoma | Q36356458 | ||
| Flexibility of mouse classical and plasmacytoid-derived dendritic cells in directing T helper type 1 and 2 cell development: dependency on antigen dose and differential toll-like receptor ligation | Q36370469 | ||
| Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses | Q36376333 | ||
| The role of stroma in immune recognition and destruction of well-established solid tumors | Q36387256 | ||
| Regulatory T cells and Toll-like receptors in tumor immunity | Q36392367 | ||
| Definition of target antigens for naturally occurring CD4(+) CD25(+) regulatory T cells | Q36402710 | ||
| Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer | Q36404654 | ||
| Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction | Q40437839 | ||
| Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells | Q40498116 | ||
| Inhibition of NF-kappaB in cancer cells converts inflammation- induced tumor growth mediated by TNFalpha to TRAIL-mediated tumor regression | Q40513415 | ||
| Autologous melanoma-induced activation of regulatory T cells that suppress cytotoxic response | Q41720666 | ||
| Human CD4(+)CD25(+) regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells [corrected]. | Q41907086 | ||
| Infectious tolerance: human CD25(+) regulatory T cells convey suppressor activity to conventional CD4(+) T helper cells | Q41908906 | ||
| Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells | Q42944333 | ||
| Analysis of regulatory CD8 T cells in Qa-1-deficient mice | Q44903222 | ||
| Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy | Q45871925 | ||
| IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis | Q46576855 | ||
| Sequence variants of toll-like receptor 4 are associated with prostate cancer risk: results from the CAncer Prostate in Sweden Study | Q47755175 | ||
| Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells | Q47991722 | ||
| Control of Foxp3+ CD25+CD4+ regulatory cell activation and function by dendritic cells | Q50095546 | ||
| Role for IL-10 in suppression mediated by peptide-induced regulatory T cells in vivo | Q56904016 | ||
| Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma | Q56904280 | ||
| Human CD4+ T Cells Express TLR5 and Its Ligand Flagellin Enhances the Suppressive Capacity and Expression of FOXP3 in CD4+CD25+ T Regulatory Cells | Q57447880 | ||
| Sequence Variants in Toll-Like Receptor Gene Cluster (TLR6-TLR1-TLR10) and Prostate Cancer Risk | Q61853345 | ||
| Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide | Q73688337 | ||
| Origin of regulatory T cells with known specificity for antigen | Q74381747 | ||
| Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells | Q77291206 | ||
| Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells | Q78806915 | ||
| Cutting edge: self-peptides drive the peripheral expansion of CD4+CD25+ regulatory T cells | Q79317453 | ||
| Reviving suppression? | Q79841487 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 17-23 | |
| P577 | publication date | 2006-07-13 | |
| P1433 | published in | Seminars in Immunopathology | Q15724576 |
| P1476 | title | Regulatory T cells and innate immune regulation in tumor immunity | |
| P478 | volume | 28 |
| Q48201872 | A role for T-bet-mediated tumour immune surveillance in anti-IL-17A treatment of lung cancer |
| Q36821572 | Adenosine as an endogenous immunoregulator in cancer pathogenesis: where to go? |
| Q37437275 | Blockade of MCP-1/CCR4 signaling-induced recruitment of activated regulatory cells evokes an antitumor immune response in head and neck squamous cell carcinoma |
| Q50960953 | Cancerous HLA class I expression and regulatory T cell infiltration in gastric cancer. |
| Q87033216 | Changes of Th17/Tc17 and Th17/Treg cells in endometrial carcinoma |
| Q39100186 | Circulating T regulatory cells migration and phenotype in glioblastoma patients: an in vitro study |
| Q35570420 | Distribution, characterization, and induction of CD8+ regulatory T cells and IL-17-producing CD8+ T cells in nasopharyngeal carcinoma. |
| Q50318735 | Effects of iodine-131 radiotherapy on Th17/Tc17 and Treg/Th17 cells of patients with differentiated thyroid carcinoma |
| Q64071947 | Gastric Cancer Stem Cells Effect on Th17/Treg Balance; A Bench to Beside Perspective |
| Q36049894 | Hepatocellular carcinoma and macrophage interaction induced tumor immunosuppression via Treg requires TLR4 signaling |
| Q55516289 | High levels of CCL2 or CCL4 in the tumor microenvironment predict unfavorable survival in lung adenocarcinoma. |
| Q34616226 | Histone deacetylase 11: A novel epigenetic regulator of myeloid derived suppressor cell expansion and function |
| Q37413874 | IFN-alpha enhances peptide vaccine-induced CD8+ T cell numbers, effector function, and antitumor activity |
| Q92619203 | Imbalance of Th1/Th2 and Th17/Treg during the development of uterine cervical cancer |
| Q44798815 | Immune response in cervical lymph nodes from patients with primary oral squamous cell carcinoma |
| Q34265357 | Immunity over inability: The spontaneous regression of cancer |
| Q39628849 | In vitro selective depletion of CD4(+)CD25(+) regulatory T-cells from PBMC using anti-tac-SAP. |
| Q35895255 | Increased P-35, EBI3 Transcripts and Other Treg Markers in Peripheral Blood Mononuclear Cells of Breast Cancer Patients with Different clinical Stages |
| Q41066538 | Low intratumoral regulatory T cells and high peritumoral CD8(+) T cells relate to long-term survival in patients with pancreatic ductal adenocarcinoma after pancreatectomy |
| Q34847859 | Mesothelin virus-like particle immunization controls pancreatic cancer growth through CD8+ T cell induction and reduction in the frequency of CD4+ foxp3+ ICOS- regulatory T cells. |
| Q50042197 | New Insights into the Tumor Microenvironment Utilizing Protein Array Technology |
| Q42554303 | Regulatory T cells and the PD-L1/PD-1 pathway mediate immune suppression in malignant human brain tumors. |
| Q35218562 | Resiquimod as an immunologic adjuvant for NY-ESO-1 protein vaccination in patients with high-risk melanoma |
| Q42323672 | T regulatory cell markers in oral squamous cell carcinoma: Relationship with survival and tumor aggressiveness. |
| Q61812765 | The Oncogene Addiction Switch from NOTCH to PI3K Requires Simultaneous Targeting of NOTCH and PI3K Pathway Inhibition in Glioblastoma |
| Q33631986 | The role of regulatory T cells in cancer |
| Q35798986 | Trial watch: Naked and vectored DNA-based anticancer vaccines |
| Q64099099 | Zoledronic acid blocks the interaction between breast cancer cells and regulatory T-cells |
| Q49481424 | hPMSC transplantation restoring ovarian function in premature ovarian failure mice is associated with change of Th17/Tc17 and Th17/Treg cell ratios through the PI3K/Akt signal pathway |
Search more.